{"id":1807,"date":"2026-01-05T11:08:59","date_gmt":"2026-01-05T10:08:59","guid":{"rendered":"https:\/\/www.sgd-pharma.com\/%e2%9c%a8-looking-ahead-to-2026-%e2%9c%a8\/"},"modified":"2026-11-13T16:32:53","modified_gmt":"2026-11-13T15:32:53","slug":"sgd-pharma-strategy-2026-olivier-russeau","status":"publish","type":"post","link":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/","title":{"rendered":"Looking Ahead to 2026: SGD Pharma&#8217;s Strategy and Priorities"},"content":{"rendered":"<div class=\"trait-block max-w-3xl mx-auto px-4 mt-10 mb-3\">\n  <svg class=\"w-7 h-auto text-blue\" viewBox=\"0 0 28 7\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n  <path d=\"M27.4629 0C27.4629 3.75941 24.4153 6.80702 20.6559 6.80702L0.000976265 6.80702C0.000976429 3.04761 3.04858 -1.06718e-06 6.808 -9.02854e-07L27.4629 0Z\" fill=\"currentColor\"\/>\n<\/svg><\/div>\n\n\n<section class=\"pt-28 md:pt-32 pb-0 \">\n      <div class=\"container hidden md:block pb-8 md:pb-16\">\n      <nav class=\"breadcrumb uppercase [&#038;_a]:text-blue text-xs font-medium \" class=\"[&#038;_span]:flex [&#038;_span]:items-center\" aria-label=\"Breadcrumb\">\n    <div id=\"breadcrumbs\"><span><span><a href=\"https:\/\/www.sgd-pharma.com\/en\/\">Home<\/a><\/span><\/span><\/div>\n  <\/nav>\n    <\/div>\n    <div class=\"container max-w-4xl text-center md:mt-15\">\n          <span class=\"inline-block text-xs font-medium tracking-[0.25em] uppercase text-blackbody mb-2.5\">january 5, 2026<\/span>\n    \n          <h1 class=\"text-[26px] leading-snug text-blackbody [&amp;_strong]:text-blue [&#038;_strong]:font-bold\">\n        Looking Ahead to 2026: SGD Pharma&#8217;s Strategy and Priorities\n      <\/h1>\n    \n    \n  <\/div>\n\n      \n    <div class=\"mt-12 w-full overflow-hidden h-62 md:h-auto md:aspect-[1400\/526]\">\n                        <img loading=\"lazy\" decoding=\"async\" width=\"1707\" height=\"1058\" src=\"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-1-e1794583959666.avif\" class=\"w-full h-full object-cover\" alt=\"Portait picture of SGD Pharma&#039;s CEO, Olivier Russeau.\" srcset=\"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-1-e1794583959666.avif 1707w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-1-e1794583959666-300x186.avif 300w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-1-e1794583959666-1024x635.avif 1024w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-1-e1794583959666-768x476.avif 768w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-1-e1794583959666-1536x952.avif 1536w\" sizes=\"auto, (max-width: 1707px) 100vw, 1707px\" \/>\n                  <\/div>\n  \n<\/section>\n\n\n\n<p class=\"wp-block-paragraph\"><br>As we begin 2026, <strong>SGD Pharma <a href=\"https:\/\/www.sgd-pharma.com\/en\/governance\/\" data-type=\"page\" data-id=\"997\">CEO<\/a> Olivier Rousseau<\/strong> reflects on a year of challenges, progress and collective achievements.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Throughout 2025, our teams worked together to strengthen our industrial performance, advance sustainability and support innovation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Now, we look ahead with a clear strategy. Our priorities for 2026 focus on three key areas: <strong>sustainability, operational excellence, and growth and innovation<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Sustainability: Advancing Our Climate Commitments<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.sgd-pharma.com\/en\/sustainability\/\" data-type=\"page\" data-id=\"487\">Sustainability<\/a> remains a central part of SGD Pharma&#8217;s strategy for 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We have set a clear target to <strong>reduce CO\u2082 emissions by 42% between 2022 and 2030<\/strong>. The Science Based Targets initiative (SBTi) has validated this commitment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In 2025, SGD Pharma also earned <strong>EcoVadis Platinum status<\/strong>. This recognition places us among the top 1% of glass manufacturers worldwide for ESG performance, according to the assessment highlighted in our year-end message.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Moreover, we plan to build our first hybrid furnace in 2026. This investment will support our efforts to modernize glass manufacturing and reduce its environmental impact.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Together, these initiatives reflect our long-term commitment to more responsible industrial operations.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Operational Excellence: Investing in Our Manufacturing Network<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.sgd-pharma.com\/en\/know-how\/\" data-type=\"page\" data-id=\"482\">Industrial performance<\/a> is another major priority.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In 2025, several SGD Pharma business units and manufacturing sites delivered strong results.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">At the same time, we committed a record level of capital expenditure (CAPEX) to modernize our furnaces and production lines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These investments aim to strengthen our manufacturing capabilities and support long-term operational performance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As a result, we continue to prepare our industrial network for the evolving needs of the pharmaceutical packaging market.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Growth and Innovation: Expanding Our Capabilities<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Growth and <a href=\"https:\/\/www.sgd-pharma.com\/en\/pharma\/innovation-pharma\/\" data-type=\"page\" data-id=\"2296\">innovation<\/a> will also shape SGD Pharma&#8217;s priorities in 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">During 2025, we launched new solutions and accelerated the development of our global tubular glass business.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A major milestone was the <strong><a href=\"https:\/\/www.sgd-pharma.com\/en\/a-strategic-step-forward-alphial-s-r-l-joins-sgd-pharma\/\" data-type=\"post\" data-id=\"5828\">acquisition of Alphial<\/a><\/strong>. This strategic move strengthens our position in pharmaceutical ampoules and ready-to-use (RTU) vials.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition, it expands our capabilities and supports our ambition to serve pharmaceutical customers worldwide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These developments provide a strong foundation for future growth.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Moving Forward Together in 2026<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Our progress would not be possible without the dedication of our employees.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Across SGD Pharma&#8217;s international teams, colleagues continue to contribute their expertise, commitment and energy every day.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We sincerely thank everyone for their hard work throughout 2025.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As we begin 2026, SGD Pharma CEO Olivier Rousseau reflects on a year of challenges,&hellip;<\/p>\n","protected":false},"author":1,"featured_media":7534,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[93],"tags":[],"class_list":["post-1807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SGD Pharma Strategy 2026: CEO&#039;s Vision &amp; Priorities<\/title>\n<meta name=\"description\" content=\"Discover SGD Pharma&#039;s strategy for 2026 as CEO Olivier Rousseau reflects on sustainability, industrial excellence, innovation and growth.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SGD Pharma Strategy 2026: CEO&#039;s Vision &amp; Priorities\" \/>\n<meta property=\"og:description\" content=\"Discover SGD Pharma&#039;s strategy for 2026 as CEO Olivier Rousseau reflects on sustainability, industrial excellence, innovation and growth.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/\" \/>\n<meta property=\"og:site_name\" content=\"SGD Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-05T10:08:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-13T15:32:53+00:00\" \/>\n<meta name=\"author\" content=\"apsulis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"apsulis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/\"},\"author\":{\"name\":\"apsulis\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/7a0cab6b1b50891788158c61b9734922\"},\"headline\":\"Looking Ahead to 2026: SGD Pharma&#8217;s Strategy and Priorities\",\"datePublished\":\"2026-01-05T10:08:59+00:00\",\"dateModified\":\"2026-11-13T15:32:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/\"},\"wordCount\":368,\"image\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sgd-pharma.com\\\/app\\\/uploads\\\/2026\\\/01\\\/olivier-rousseau-3-e1794583545442.avif\",\"articleSection\":[\"Corporate\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/\",\"url\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/\",\"name\":\"SGD Pharma Strategy 2026: CEO's Vision & Priorities\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sgd-pharma.com\\\/app\\\/uploads\\\/2026\\\/01\\\/olivier-rousseau-3-e1794583545442.avif\",\"datePublished\":\"2026-01-05T10:08:59+00:00\",\"dateModified\":\"2026-11-13T15:32:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/7a0cab6b1b50891788158c61b9734922\"},\"description\":\"Discover SGD Pharma's strategy for 2026 as CEO Olivier Rousseau reflects on sustainability, industrial excellence, innovation and growth.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sgd-pharma.com\\\/app\\\/uploads\\\/2026\\\/01\\\/olivier-rousseau-3-e1794583545442.avif\",\"contentUrl\":\"https:\\\/\\\/www.sgd-pharma.com\\\/app\\\/uploads\\\/2026\\\/01\\\/olivier-rousseau-3-e1794583545442.avif\",\"width\":1707,\"height\":1566,\"caption\":\"Portait picture of the CEO of SGD Pharma, Olivier Russeau\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/sgd-pharma-strategy-2026-olivier-russeau\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Looking Ahead to 2026: SGD Pharma&#8217;s Strategy and Priorities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/\",\"name\":\"SGD Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/7a0cab6b1b50891788158c61b9734922\",\"name\":\"apsulis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g\",\"caption\":\"apsulis\"},\"sameAs\":[\"https:\\\/\\\/www.sgd-pharma.com\\\/wp\"],\"url\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/author\\\/apsulis\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SGD Pharma Strategy 2026: CEO's Vision & Priorities","description":"Discover SGD Pharma's strategy for 2026 as CEO Olivier Rousseau reflects on sustainability, industrial excellence, innovation and growth.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/","og_locale":"en_US","og_type":"article","og_title":"SGD Pharma Strategy 2026: CEO's Vision & Priorities","og_description":"Discover SGD Pharma's strategy for 2026 as CEO Olivier Rousseau reflects on sustainability, industrial excellence, innovation and growth.","og_url":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/","og_site_name":"SGD Pharma","article_published_time":"2026-01-05T10:08:59+00:00","article_modified_time":"2026-11-13T15:32:53+00:00","author":"apsulis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"apsulis","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/#article","isPartOf":{"@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/"},"author":{"name":"apsulis","@id":"https:\/\/www.sgd-pharma.com\/en\/#\/schema\/person\/7a0cab6b1b50891788158c61b9734922"},"headline":"Looking Ahead to 2026: SGD Pharma&#8217;s Strategy and Priorities","datePublished":"2026-01-05T10:08:59+00:00","dateModified":"2026-11-13T15:32:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/"},"wordCount":368,"image":{"@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-e1794583545442.avif","articleSection":["Corporate"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/","url":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/","name":"SGD Pharma Strategy 2026: CEO's Vision & Priorities","isPartOf":{"@id":"https:\/\/www.sgd-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/#primaryimage"},"image":{"@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-e1794583545442.avif","datePublished":"2026-01-05T10:08:59+00:00","dateModified":"2026-11-13T15:32:53+00:00","author":{"@id":"https:\/\/www.sgd-pharma.com\/en\/#\/schema\/person\/7a0cab6b1b50891788158c61b9734922"},"description":"Discover SGD Pharma's strategy for 2026 as CEO Olivier Rousseau reflects on sustainability, industrial excellence, innovation and growth.","breadcrumb":{"@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/#primaryimage","url":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-e1794583545442.avif","contentUrl":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/01\/olivier-rousseau-3-e1794583545442.avif","width":1707,"height":1566,"caption":"Portait picture of the CEO of SGD Pharma, Olivier Russeau"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-strategy-2026-olivier-russeau\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sgd-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Looking Ahead to 2026: SGD Pharma&#8217;s Strategy and Priorities"}]},{"@type":"WebSite","@id":"https:\/\/www.sgd-pharma.com\/en\/#website","url":"https:\/\/www.sgd-pharma.com\/en\/","name":"SGD Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sgd-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sgd-pharma.com\/en\/#\/schema\/person\/7a0cab6b1b50891788158c61b9734922","name":"apsulis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g","caption":"apsulis"},"sameAs":["https:\/\/www.sgd-pharma.com\/wp"],"url":"https:\/\/www.sgd-pharma.com\/en\/author\/apsulis\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1807"}],"version-history":[{"count":3,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1807\/revisions"}],"predecessor-version":[{"id":7539,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1807\/revisions\/7539"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/media\/7534"}],"wp:attachment":[{"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=1807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=1807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}